Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2417864
Max Phase: Preclinical
Molecular Formula: C23H20N4O3S
Molecular Weight: 432.51
Molecule Type: Small molecule
Associated Items:
ID: ALA2417864
Max Phase: Preclinical
Molecular Formula: C23H20N4O3S
Molecular Weight: 432.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)CNC(=O)c1ccc(NC(=S)NN=C(c2ccccc2)c2ccccc2)cc1
Standard InChI: InChI=1S/C23H20N4O3S/c28-20(29)15-24-22(30)18-11-13-19(14-12-18)25-23(31)27-26-21(16-7-3-1-4-8-16)17-9-5-2-6-10-17/h1-14H,15H2,(H,24,30)(H,28,29)(H2,25,27,31)
Standard InChI Key: NYRQMBFXUXOSPH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 432.51 | Molecular Weight (Monoisotopic): 432.1256 | AlogP: 3.24 | #Rotatable Bonds: 7 |
Polar Surface Area: 102.82 | Molecular Species: ACID | HBA: 4 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.42 | CX Basic pKa: 2.02 | CX LogP: 4.01 | CX LogD: 0.80 |
Aromatic Rings: 3 | Heavy Atoms: 31 | QED Weighted: 0.26 | Np Likeness Score: -1.19 |
1. El-Sharief MA, Abbas SY, El-Bayouki KA, El-Bayouki KA, El-Gammal EW.. (2013) Synthesis of thiosemicarbazones derived from N-(4-hippuric acid)thiosemicarbazide and different carbonyl compounds as antimicrobial agents., 67 [PMID:23871906] [10.1016/j.ejmech.2013.06.031] |
Source(1):